Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessspermatid development

AXDND1 SEPTIN4 ING2 TTC21A PRKG1 CFAP157

9.23e-05262586GO:0007286
GeneOntologyBiologicalProcessspermatid differentiation

AXDND1 SEPTIN4 ING2 TTC21A PRKG1 CFAP157

1.13e-04272586GO:0048515
GeneOntologyBiologicalProcessflagellated sperm motility

DNAI1 SEPTIN4 ING2 TTC21A CFAP157

1.76e-04186585GO:0030317
GeneOntologyBiologicalProcesssperm motility

DNAI1 SEPTIN4 ING2 TTC21A CFAP157

2.09e-04193585GO:0097722
GeneOntologyBiologicalProcessspermatogenesis

AXDND1 IGF2R SEPTIN4 ING2 TTC21A UPF3A PRKG1 STK31 CFAP157

2.15e-04744589GO:0007283
GeneOntologyBiologicalProcessmale gamete generation

AXDND1 IGF2R SEPTIN4 ING2 TTC21A UPF3A PRKG1 STK31 CFAP157

2.57e-04762589GO:0048232
GeneOntologyBiologicalProcesscilium movement involved in cell motility

DNAI1 SEPTIN4 ING2 TTC21A CFAP157

3.08e-04210585GO:0060294
GeneOntologyBiologicalProcesscilium or flagellum-dependent cell motility

DNAI1 SEPTIN4 ING2 TTC21A CFAP157

3.44e-04215585GO:0001539
GeneOntologyBiologicalProcesscilium-dependent cell motility

DNAI1 SEPTIN4 ING2 TTC21A CFAP157

3.44e-04215585GO:0060285
GeneOntologyBiologicalProcessactin cytoskeleton organization

TPM2 TPM3 TPM4 HSP90B1 GRID2IP PRKG1 DIAPH3 NOSTRIN NEB

3.78e-04803589GO:0030036
GeneOntologyBiologicalProcessgerm cell development

AXDND1 SEPTIN4 ING2 TTC21A PRKG1 STK31 CFAP157

3.91e-04482587GO:0007281
GeneOntologyCellularComponentmuscle thin filament tropomyosin

TPM2 TPM3 TPM4

8.09e-084583GO:0005862
GeneOntologyCellularComponentstriated muscle thin filament

TPM2 TPM3 TPM4 NEB

8.93e-0727584GO:0005865
GeneOntologyCellularComponentmyofilament

TPM2 TPM3 TPM4 NEB

1.81e-0632584GO:0036379
GeneOntologyCellularComponentcell division site

TPM3 SEPTIN4 DIAPH3 STAMBP

7.21e-0580584GO:0032153
GeneOntologyCellularComponentclathrin coat

SYNRG IGF2R STON1

5.06e-0456583GO:0030118
GeneOntologyCellularComponentcleavage furrow

TPM3 DIAPH3 STAMBP

6.51e-0461583GO:0032154
GeneOntologyCellularComponentactin filament

TPM2 TPM3 TPM4 DIAPH3

7.23e-04146584GO:0005884
HumanPhenoIntercostal muscle weakness

TPM2 TPM3 LAMA2

7.13e-0611193HP:0004878
HumanPhenoNeuromuscular dysphagia

TPM2 TPM3 NEB

7.13e-0611193HP:0002068
HumanPhenoNeck muscle weakness

TPM2 TPM3 LAMA2 TGM6 NEB

1.92e-0595195HP:0000467
HumanPhenoAbnormal morphology of the musculature of the neck

TPM2 TPM3 LAMA2 TGM6 NEB SYNGAP1

2.47e-05171196HP:0011006
HumanPhenoHypokinesia

TPM2 TPM3 LAMA2 NEB

3.89e-0554194HP:0002375
HumanPhenoNemaline bodies

TPM2 TPM3 NEB

4.11e-0519193HP:0003798
HumanPhenoHypoventilation

TPM2 TPM3 LAMA2 NEB

4.18e-0555194HP:0002791
HumanPhenoGeneralized limb muscle atrophy

TPM2 TPM3 NEB

4.82e-0520193HP:0009055
HumanPhenoMyopathic facies

TPM2 TPM3 LAMA2 NEB

4.82e-0557194HP:0002058
HumanPhenoFatiguable weakness of proximal limb muscles

TPM2 TPM3 NEB

6.48e-0522193HP:0030200
HumanPhenoSlender build

TPM2 TPM3 SARS1 NEB

8.61e-0566194HP:0001533
HumanPhenoReduced vital capacity

TPM2 TPM3 NEB

1.51e-0429193HP:0002792
HumanPhenoDiminished movement

TPM2 TPM3 LAMA2 NEB

2.01e-0482194HP:0002374
HumanPhenoMuscle fiber cytoplasmatic inclusion bodies

TPM2 TPM3 NEB

2.04e-0432193HP:0100303
HumanPhenoFetal akinesia sequence

TPM2 TPM3 NEB

2.45e-0434193HP:0001989
HumanPhenoAbnormality of habitus

TPM2 TPM3 SARS1 NEB

2.53e-0487194HP:0010718
HumanPhenoRespiratory failure

TPM2 TPM3 DNAI1 ABCA3 LAMA2 NEB

2.69e-04262196HP:0002878
HumanPhenoFatigable weakness of distal limb muscles

TPM2 NEB

3.64e-048192HP:0030198
HumanPhenoIncreased muscle lipid content

TPM2 TPM3 NEB

3.98e-0440193HP:0009058
HumanPhenoMuscle fiber inclusion bodies

TPM2 TPM3 NEB

3.98e-0440193HP:0100299
HumanPhenoRespiratory insufficiency due to muscle weakness

TPM2 TPM3 LAMA2 NEB

4.84e-04103194HP:0002747
HumanPhenoBulbar signs

TPM2 TPM3 NEB

5.29e-0444193HP:0002483
HumanPhenoFacial diplegia

TPM2 TPM3 NEB

5.29e-0444193HP:0001349
HumanPhenoFatigable weakness of skeletal muscles

TPM2 TPM3 NEB

5.66e-0445193HP:0030197
HumanPhenoMask-like facies

TPM2 TPM3 LAMA2 NEB

6.00e-04109194HP:0000298
HumanPhenoNeck flexor weakness

TPM2 LAMA2 NEB

6.04e-0446193HP:0003722
HumanPhenoAbnormal blood oxygen level

TPM2 TPM3 ABCA3

6.85e-0448193HP:0500165
HumanPhenoHypoxemia

TPM2 TPM3 ABCA3

6.85e-0448193HP:0012418
HumanPhenoIncreased variability in muscle fiber diameter

TPM2 TPM3 LAMA2 NEB

7.60e-04116194HP:0003557
HumanPhenoWeakness of muscles of respiration

TPM2 TPM3 LAMA2 NEB

7.60e-04116194HP:0004347
HumanPhenoCentral hypoventilation

TPM2 TPM3

8.51e-0412192HP:0007110
HumanPhenoImpaired mastication

TPM2 TPM3 LAMA2

8.66e-0452193HP:0005216
HumanPhenoAbnormality of skeletal muscle fiber size

TPM2 TPM3 LAMA2 NEB

8.91e-04121194HP:0012084
HumanPhenoAbnormal blood gas level

TPM2 TPM3 ABCA3

9.16e-0453193HP:0012415
HumanPhenoDifficulty walking and climbing stairs

TPM2 TPM3 LAMA2

9.68e-0454193HP:0007019
HumanPhenoDifficulty running

TPM2 TPM3 LAMA2

9.68e-0454193HP:0009046
HumanPhenoDifficulty walking

TPM2 TPM3 LAMA2

9.68e-0454193HP:0002355
HumanPhenoAbnormal muscle tissue metabolite concentration

TPM2 TPM3 NEB

9.68e-0454193HP:0034370
HumanPhenoAnkle flexion contracture

TPM2 TPM3 NEB

1.08e-0356193HP:0006466
HumanPhenoTall stature

TPM2 TPM3 SARS1 PRKG1 NEB

1.12e-03225195HP:0000098
HumanPhenoWaddling gait

TPM2 TPM3 LAMA2 NEB

1.17e-03130194HP:0002515
HumanPhenoAbnormal blood carbon dioxide level

TPM2 TPM3

1.17e-0314192HP:0500164
HumanPhenoHypercapnia

TPM2 TPM3

1.17e-0314192HP:0012416
HumanPhenoSpinal rigidity

TPM2 TPM3 NEB

1.25e-0359193HP:0003306
HumanPhenoBreech presentation

TPM2 TPM3 NEB

1.25e-0359193HP:0001623
HumanPhenoAnkle contracture

TPM2 TPM3 NEB

1.32e-0360193HP:0034677
HumanPhenoCor pulmonale

TPM2 TPM3

1.34e-0315192HP:0001648
HumanPhenoFatigable weakness of bulbar muscles

TPM2 TPM3 NEB

1.38e-0361193HP:0030192
HumanPhenoNocturnal hypoventilation

TPM2 NEB

1.53e-0316192HP:0002877
HumanPhenoMildly elevated creatine kinase

TPM2 TPM3 NEB

1.59e-0364193HP:0008180
DomainTROPOMYOSIN

TPM2 TPM3 TPM4

1.08e-074573PS00326
DomainTropomyosin

TPM2 TPM3 TPM4

1.08e-074573IPR000533
DomainTropomyosin

TPM2 TPM3 TPM4

1.08e-074573PF00261
DomainHR1_rho-bd

FNBP1 KRT77 NOSTRIN

5.91e-0525573IPR011072
DomainING

ING2 ING5

9.10e-055572SM01408
DomainING_N_histone_binding

ING2 ING5

9.10e-055572IPR024610
DomainING

ING2 ING5

9.10e-055572PF12998
DomainING_fam

ING2 ING5

9.10e-055572IPR028651
DomainFH2

GRID2IP DIAPH3

9.37e-0415572PS51444
DomainFH2_Formin

GRID2IP DIAPH3

9.37e-0415572IPR015425
DomainFH2

GRID2IP DIAPH3

9.37e-0415572PF02181
DomainFH2

GRID2IP DIAPH3

9.37e-0415572SM00498
DomainSH3_9

FNBP1 NOSTRIN NEB

1.74e-0378573PF14604
DomainCyclophilin-type_PPIase

PPIL4 PPWD1

1.85e-0321572IPR024936
DomainFCH

FNBP1 NOSTRIN

2.03e-0322572PF00611
DomainCyclophilin-like_dom

PPIL4 PPWD1

2.03e-0322572IPR029000
DomainCSA_PPIASE_2

PPIL4 PPWD1

2.03e-0322572PS50072
DomainPro_isomerase

PPIL4 PPWD1

2.03e-0322572PF00160
Domain-

PPIL4 PPWD1

2.03e-03225722.40.100.10
DomainCyclophilin-type_PPIase_dom

PPIL4 PPWD1

2.03e-0322572IPR002130
DomainCSA_PPIASE_1

PPIL4 PPWD1

2.03e-0322572PS00170
DomainFCH_dom

FNBP1 NOSTRIN

2.22e-0323572IPR001060
DomaintRNA-bd_arm

SARS1 PRKG1

2.42e-0324572IPR010978
DomainF_BAR

FNBP1 NOSTRIN

2.62e-0325572IPR031160
DomainF_BAR

FNBP1 NOSTRIN

2.62e-0325572PS51741
PathwayREACTOME_STRIATED_MUSCLE_CONTRACTION

TPM2 TPM3 TPM4 NEB

3.33e-0635424MM15005
PathwayREACTOME_STRIATED_MUSCLE_CONTRACTION

TPM2 TPM3 TPM4 NEB

3.74e-0636424M18647
PathwayWP_STRIATED_MUSCLE_CONTRACTION_PATHWAY

TPM2 TPM3 TPM4 NEB

4.67e-0638424M39549
PathwayKEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM

TPM2 TPM3 TPM4 LAMA2

1.05e-0483424M8728
PathwayKEGG_DILATED_CARDIOMYOPATHY

TPM2 TPM3 TPM4 LAMA2

1.44e-0490424M835
PathwayREACTOME_SMOOTH_MUSCLE_CONTRACTION

TPM2 TPM3 TPM4

1.51e-0435423MM15114
PathwayREACTOME_SMOOTH_MUSCLE_CONTRACTION

TPM2 TPM3 TPM4

2.79e-0443423M1429
Pubmed

A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism.

TPM2 TPM3 TPM4

4.40e-0935833865200
Pubmed

A systematic nomenclature for mammalian tropomyosin isoforms.

TPM2 TPM3 TPM4

1.76e-08458325369766
Pubmed

Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts.

TPM2 TPM3 TPM4

1.76e-08458316765662
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

TPM2 TPM3 TPM4 CCNH HSP90B1 GPR19 CENPF KRT77 U2SURP DIAPH3 NOSTRIN NEB TTC3 STK31

7.63e-081442581435575683
Pubmed

Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.

TPM2 TPM3 TPM4

8.77e-08658323792823
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

DNAI1 GRID2IP SARS1 CENPF U2SURP UTP3 GALNT5 NEB SYNGAP1

1.32e-0749758936774506
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

TPM2 TPM3 TPM4 HSP90B1 SARS1 POLA1 U2SURP NOL10 PPWD1

2.58e-0753858928524877
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TPM3 HSP90B1 IGF2R SARS1 STXBP3 CENPF POLA1 U2SURP PPIL4 NOL10 UTP3 GALNT5 TTC3

4.90e-071425581330948266
Pubmed

Nemaline Myopathy – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY

TPM2 TPM3 NEB

5.24e-071058320301465
Pubmed

Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

TPM2 TPM3 TPM4 NEB

2.07e-065458422266860
Pubmed

High molecular weight tropomyosins regulate osteoclast cytoskeletal morphology.

TPM2 TPM3

2.73e-06258218674650
Pubmed

Binding and phosphorylation of a novel male germ cell-specific cGMP-dependent protein kinase-anchoring protein by cGMP-dependent protein kinase Ialpha.

GKAP1 PRKG1

2.73e-06258210671526
Pubmed

Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms.

TPM2 TPM3

2.73e-06258222798622
Pubmed

Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia.

TPM2 TPM3

2.73e-06258238219297
Pubmed

Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy.

TPM2 TPM3

2.73e-06258224507666
Pubmed

Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.

TPM2 TPM3

2.73e-06258224692096
Pubmed

Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.

TPM2 TPM3 TPM4 JAK1 IGF2R

6.44e-0615658529961565
Pubmed

Smooth muscle contraction and relaxation.

TPM2 TPM3 TPM4

6.63e-062258314627618
Pubmed

Vertebrate tropomyosin: distribution, properties and function.

TPM2 TPM3

8.19e-06358211563548
Pubmed

Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin.

TPM2 TPM3

8.19e-0635828120097
Pubmed

Tumor necrosis factor (TNF)-α-induced repression of GKAP42 protein levels through cGMP-dependent kinase (cGK)-Iα causes insulin resistance in 3T3-L1 adipocytes.

GKAP1 PRKG1

8.19e-06358225586176
Pubmed

Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly.

TPM2 TPM3

8.19e-0635827568216
Pubmed

h2-Calponin is regulated by mechanical tension and modifies the function of actin cytoskeleton.

TPM3 TPM4

8.19e-06358216236705
Pubmed

U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation.

U2SURP UPF3A

8.19e-06358230977118
Pubmed

Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins.

TPM2 TPM3

1.64e-0545829092943
Pubmed

Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease.

TPM2 TPM3

1.64e-0545821516138
Pubmed

Actin and tropomyosin isoforms in morphogenesis.

TPM2 TPM3

1.64e-0545829108196
Pubmed

Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations.

TPM2 NEB

2.72e-05558225110572
Pubmed

Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis.

IL13RA1 IL33

4.08e-05658227421703
Pubmed

Congenital Fiber-Type Disproportion – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY

TPM2 TPM3

4.08e-05658220301436
Pubmed

Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia.

TPM2 TPM3 TPM4

4.16e-054058320381070
Pubmed

HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.

TPM2 TPM3 TPM4

4.49e-054158324614889
Pubmed

ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression.

ING2 ING5

5.71e-05758216728974
Pubmed

Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice.

TPM2 TPM4

5.71e-05758219118250
Pubmed

STAM2, a new member of the STAM family, binding to the Janus kinases.

JAK1 STAMBP

7.60e-05858210899310
Pubmed

Insights into the ubiquitin-proteasome system of human embryonic stem cells.

TPM3 TPM4 HSP90B1 U2SURP PPIL4

8.74e-0526958529511261
Pubmed

Members of the Zyxin family of LIM proteins interact with members of the p130Cas family of signal transducers.

TPM4 SYNGAP1

9.77e-05958211782456
Pubmed

Modulation of gene expression in the preimplantation mouse embryo by TGF-alpha and TGF-beta.

HSP90B1 POLA1

1.22e-04105827654366
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

TPM3 AXDND1 CCDC83 IL13RA1 LAMA2 NOSTRIN TTC3

1.42e-0468658729987050
Pubmed

Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening.

PRKG1 TTC3 STAMBP

1.48e-046158335205757
Pubmed

A human MAP kinase interactome.

TPM4 HSP90B1 ING5 NOSTRIN NEB STAMBP

1.58e-0448658620936779
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

TPM3 TPM4 HSP90B1 SARS1 CENPF KRT77 NOL10 DIAPH3 UTP3 TTC3

1.67e-041496581032877691
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

TPM2 TPM3 TPM4 HSP90B1 ING2 U2SURP NOL10 UTP3

1.71e-0494958836574265
Pubmed

mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.

TPM3 TPM4 HSP90B1 IGF2R KRT77

1.75e-0431258537120454
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

TPM2 TPM3 LAMA2 NOSTRIN NEB TTC3

1.78e-0449758623414517
Pubmed

Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.

JAK1 IL13RA1

1.78e-041258212207328
Pubmed

Vimentin is a novel AKT1 target mediating motility and invasion.

TPM2 TPM4

1.78e-041258220856200
Pubmed

Molecular diversity of myofibrillar proteins: gene regulation and functional significance.

TPM2 NEB

1.78e-04125828618961
Pubmed

Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

TPM2 TPM3

1.78e-04125828424456
Pubmed

A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.

TPM2 TPM3 TPM4 HSP90B1 IGF2R CLHC1

1.90e-0450358636217030
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

SYNRG SARS1 POLA1 GKAP1 PPIL4 DIAPH3 TTC3

1.97e-0472458736232890
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

HSP90B1 CENPF U2SURP PPIL4 PWWP3A NOL10 UTP3 SPTY2D1

2.26e-0498958836424410
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

TPM2 JAK1 CENPF HMGXB3 TTC3

2.33e-0433258537433992
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

TPM4 IGF2R STXBP3 CENPF POLA1 NOL10 SPTY2D1

2.52e-0475458733060197
Pubmed

Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis.

TPM3 TPM4 HSP90B1

2.62e-047458316130169
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

TPM3 JAK1 HSP90B1 KRT77 U2SURP PPIL4

3.10e-0455158634728620
Pubmed

MusTRD can regulate postnatal fiber-specific expression.

TPM2 TPM3

3.23e-041658216494860
Pubmed

GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion.

HSP90B1 IGF2R

3.66e-041758217634284
Pubmed

Novel cell lines promote the discovery of genes involved in early heart development.

TPM2 JAK1

4.11e-041858211437454
Pubmed

PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis.

ABCA3 CENPF

5.09e-042058234497269
Pubmed

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.

JAK1 U2SURP PPIL4 STK31

5.23e-0422258435941108
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

TPM3 TPM4 HSP90B1 SARS1 SEPTIN4 TTC21A GKAP1 DGKB SYNGAP1

5.69e-04143158937142655
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

HSP90B1 CENPF PWWP3A UTP3 SPTY2D1

6.09e-0441058526949251
Pubmed

α-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation.

TPM3 HSP90B1

6.18e-042258220111909
Pubmed

Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons.

HSP90B1 IGF2R

6.76e-042358218001291
Pubmed

DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer.

TPM2 TPM3 TPM4 KRT77

6.79e-0423858435864588
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

IGF2R CENPF POLA1 ATAD2B U2SURP NOL10

7.57e-0465358622586326
Pubmed

Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.

TPM2 TPM3 TPM4 HSP90B1

9.30e-0425958431162944
Pubmed

A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.

TPM2 TPM4 CENPF

1.03e-0311858330979931
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

TPM2 TPM3 TPM4 JAK1

1.06e-0326858433024031
Pubmed

Integrating genetic and network analysis to characterize genes related to mouse weight.

NOL10 NEB

1.08e-032958216934000
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

TPM3 TPM4 HSP90B1 CENPF KRT77 PPIL4 NOL10 UTP3

1.10e-03125758836526897
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

TPM2 IGF2R CENPF POLA1 NOL10

1.14e-0347258538943005
Pubmed

Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.

TPM3 TPM4

1.31e-033258221951318
Pubmed

HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

CENPF POLA1

1.31e-033258227114546
Pubmed

Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.

TPM4 JAK1 HSP90B1 IGF2R

1.32e-0328558421423176
Pubmed

Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia.

TPM2 TPM3 CCNH SPTY2D1

1.45e-0329258412819125
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

CCNH CENPF POLA1 U2SURP PPIL4

1.55e-0350658530890647
Pubmed

Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.

TPM3 TPM4

1.57e-033558227812135
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

SYNRG SARS1 STXBP3 PPIL4 UPF3A DIAPH3 IL33

1.65e-03103858726673895
InteractionPLCH2 interactions

TPM2 TPM3 TPM4

4.89e-0612583int:PLCH2
InteractionFBXO22 interactions

DNAI1 GRID2IP SARS1 CENPF U2SURP UTP3 GALNT5 NEB SYNGAP1

2.20e-05540589int:FBXO22
Cytoband5q12.3

NLN PPWD1

2.37e-04185825q12.3
CytobandEnsembl 112 genes in cytogenetic band chr5q12

NLN PPWD1

3.19e-0366582chr5q12
Cytoband1p13.3

SARS1 STXBP3

3.49e-03695821p13.3
GeneFamilyTropomyosins

TPM2 TPM3 TPM4

3.15e-084373777
GeneFamilyCyclophilin peptidylprolyl isomerases

PPIL4 PPWD1

6.82e-0419372909
GeneFamilyRho GTPase activating proteins|F-BAR domain containing

FNBP1 NOSTRIN

1.00e-03233721288
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

CCNH FNBP1 HSP90B1 GPR19 STXBP3 GKAP1 PPIL4 UPF3A DIAPH3 PPWD1

1.59e-066565810M18979
CoexpressionGSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN

TPM4 HSP90B1 CENPF DNAJC25 ZBTB8A STK31

3.62e-06187586M4905
CoexpressionFAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2

TPM2 TPM4 JAK1 SEPTIN4 LAMA2 PRKG1

5.55e-05303586M39040
CoexpressionZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1

TPM4 HSP90B1 ZBTB8A TTC3

6.16e-0596584M39216
CoexpressionPYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP

CENPF POLA1 ATAD2B U2SURP ZBTB8A

7.20e-05195585M13736
CoexpressionZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR

TPM3 TPM4 HSP90B1 CENPF

7.22e-05100584M39218
CoexpressionGSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP

HSP90B1 SARS1 UPF3A UTP3 TTC3

7.93e-05199585M4473
CoexpressionAtlaskidney_adult_Mesangium_Meis_top-relative-expression-ranked_100

SEPTIN4 DGKB PRKG1 NOSTRIN

6.21e-0581564gudmap_kidney_adult_Mesangium_Meis_100
CoexpressionAtlaskidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_500

SEPTIN4 DGKB PRKG1 NOSTRIN

6.21e-0581564gudmap_kidney_adult_RenCorpuscGlomer_k1_500
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 IGF2R SEPTIN4 CENPF DGKB PRKG1 DIAPH3 NOSTRIN

7.24e-111755883e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

4.99e-09188587a906c29e3fda22eecfec3e5cac706c417bf2b7a4
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TPM2 TPM4 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

5.18e-0918958726cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TPM2 TPM4 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

5.37e-091905872ab604d35456beba71c25511e0f819000e6642d2
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 IL13RA1 IGF2R SEPTIN4 DGKB NOSTRIN

5.99e-091935877386fadc13a437f3b0c99b5d116cd3c5f893529c
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 IGF2R SEPTIN4 DGKB PRKG1 NOSTRIN

6.43e-091955876e875c83f838241b5fcaf4a3249b1408d74521dc
ToppCellfacs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 SEPTIN4 PRKG1 NOSTRIN CFAP157

1.09e-07175586bfac175b79bb7d3d81074a2407c206a7647ee75d
ToppCellfacs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 SEPTIN4 PRKG1 NOSTRIN CFAP157

1.09e-07175586c94fb35bbac95123201ca87ca835aecaefc0c490
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.24e-0717958656db12467b445f2b8ef92af50779eeab10413eb2
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 TPM4 SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.28e-0718058664956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.71e-07189586ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 IL13RA1 IGF2R SEPTIN4 LAMA2 NOSTRIN

1.77e-07190586106862ef44fcaa0971c3ba0147d13eb08015ca77
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 IGF2R SEPTIN4 LAMA2 NOSTRIN

1.77e-07190586951e067d14412db67dc3babcdf61e41717d7b429
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.77e-0719058610b02c62e72bfea9767e3e751011436925da823e
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 IGF2R SEPTIN4 LAMA2 PRKG1 NOSTRIN

2.12e-071965866708026bafd19c35c5c4e81911344d36a0f508cd
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 TPM4 IGF2R SEPTIN4 NOSTRIN

2.83e-061705851f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL13RA1 IGF2R SEPTIN4 CENPF NOSTRIN

3.26e-06175585fa16c6ba08dc0cc22e8cf049db0577811d080df6
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAI1 TTC21A CLHC1 CFAP157 SYNGAP1

3.64e-061795855e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 SEPTIN4 LAMA2 PRKG1

3.84e-06181585a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 SEPTIN4 LAMA2 PRKG1

3.84e-06181585526e858a848470b6d2d5248788004d9735ed3add
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 SEPTIN4 LAMA2 PRKG1 NOSTRIN

3.95e-06182585fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCellfacs-Heart-RA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 SEPTIN4 DGKB PRKG1 NOSTRIN

4.28e-06185585c4ef8d9f8b9769e887daac4efd9dc05738b28ae2
ToppCellfacs-Heart-RA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 SEPTIN4 DGKB PRKG1 NOSTRIN

4.28e-0618558510ddf38d908525b4258f9d2da8be4c56ebc08ff4
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 SEPTIN4 LAMA2 PRKG1 NOSTRIN

4.87e-061905851004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 SEPTIN4 DGKB PRKG1

4.87e-061905851ab3f19f1ce9f58e5125135704d94655a2e330a0
ToppCellE15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TPM2 TPM4 IGF2R SEPTIN4 NOSTRIN

4.87e-0619058584fbd5664ec886120963d4f50dfa1fd1851d36c1
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 DGKB PRKG1 NEB

4.99e-06191585f932980baa032748857cb367a55c37dd975c693e
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 IL13RA1 IGF2R SEPTIN4 NOSTRIN

5.12e-06192585430ef714bf2544d32f3fd96a55af010f79aa9be0
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 TPM4 LAMA2 PRKG1 NOSTRIN

5.12e-0619258509cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCelldroplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 SEPTIN4 DGKB PRKG1

5.25e-06193585b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 TPM4 LAMA2 PRKG1 NOSTRIN

5.25e-06193585dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 TPM4 LAMA2 PRKG1 NOSTRIN

5.25e-061935852ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCellCV-Moderate-6|CV / Virus stimulation, Condition and Cluster

TPM4 FNBP1 IGF2R TTC3 SPTY2D1

5.66e-061965857bced0cc2112697593c478fa291b8ed3941fb811
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

AXDND1 DNAI1 CENPF TTC21A CFAP157

5.81e-061975856e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCellerythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class

TPM3 HSP90B1 UPF3A GCSH TTC3

6.10e-0619958539c4adef3e02f948414f866aa22ac76f44b7b7db
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.

TPM2 HSP90B1 LAMA2 PRKG1 NEB

6.25e-062005855ba4ed490c64b3bb738e7729669f893fa73aa56f
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type.

STON1 DNAJC25 TTC21A DGKB UTP3

6.25e-062005856b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type.

STON1 DNAJC25 TTC21A DGKB UTP3

6.25e-06200585be83f442179ba4217d12f0458059586ff3130991
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 SEPTIN4 LAMA2 NOSTRIN

5.36e-0515858432c95c1bc9e50fccd6d06e828f29258fc5e568cb
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 SEPTIN4 PRKG1 NOSTRIN

5.49e-051595847a5c94c87b73f928d4daee507f32cbe7d90e4478
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

TPM2 TPM4 DGKB PRKG1

5.63e-0516058429c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

TPM2 TPM4 DGKB PRKG1

5.77e-0516158447b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 SEPTIN4 PRKG1 NOSTRIN

5.91e-05162584c5eee02836efde2108534679850c28d2b2cfce3f
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TPM2 TSPYL2 DGKB PRKG1

6.05e-051635848f24cef152f5965727bbeee116bd26c75cbba82a
ToppCellfacs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYNRG IL13RA1 NOL10 CLHC1

6.05e-05163584132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 CENPF GKAP1 GCSH

6.34e-05165584c042cde64b61ae195e1054f7b560151dabbfdf0d
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9

NLN CENPF NOL10 UTP3

6.49e-0516658452293b8a74d46e6161fb6a2e7e86e51fd9e89a5b
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ABCA3 POLA1 DIAPH3 IL33

6.49e-05166584575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCellmetastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass

TPM2 SEPTIN4 PRKG1 IL33

6.49e-051665840da2c6ea1e62f1aafabafbbfbbcc6f7011739346
ToppCellASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

TPM2 SEPTIN4 TSPYL2 LAMA2

7.45e-05172584df3800bcd9777d02900eba0cfc26ab73de8a1d95
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPR19 CENPF DIAPH3 NOSTRIN

7.79e-0517458494575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPR19 CENPF DIAPH3 NOSTRIN

7.79e-0517458440c81ab36d7931e271e20d7d56fed32463c75f41
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM2 AXDND1 CENPF DIAPH3

7.79e-051745847b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPR19 CENPF DIAPH3 NOSTRIN

7.79e-05174584b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 SEPTIN4 LAMA2 PRKG1

7.96e-051755841b4cefae400bf756d09ece32d3f5c0bd4c6ad73f
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 SEPTIN4 LAMA2 PRKG1

8.14e-05176584e9152defb4fd41267fb33c42c01fd0c683280783
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 SEPTIN4 LAMA2 PRKG1

8.14e-05176584a4d269075aa0efc46fa251b379f334e50c69391d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 SEPTIN4 LAMA2 PRKG1

8.14e-05176584cc6f65a7d2c622841c9d1ab3755586039d4ccc4d
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ABCA3 CENPF DIAPH3 IL33

8.32e-05177584a68c3688f12aee22f3cb4049c4bccacbacb0fae6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

8.32e-05177584b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ABCA3 GRID2IP CENPF DIAPH3

8.51e-05178584dbde3305e0c6a81593fe614e3f2e746b32cc16a7
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TPM2 LAMA2 DGKB PRKG1

8.69e-05179584f5bb4d3a27d56698473219970e764084096cc582
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TPM2 LAMA2 DGKB PRKG1

8.69e-05179584fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCellE15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TPM2 IL13RA1 IGF2R SEPTIN4

8.88e-0518058438035cf2c6fbc443ea10ca7e942572715ed572da
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAI1 TTC21A CLHC1 CFAP157

8.88e-0518058492fb01b91261b3103454924cde56add337b41844
ToppCellfacs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 SEPTIN4 NOSTRIN CLHC1

9.07e-051815841db1eb7d330a7e5090994007ae287e11f0a74450
ToppCellfacs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 SEPTIN4 NOSTRIN CLHC1

9.07e-0518158406174ce9240c9261c0f51a1b0d875335d60722e5
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

TPM2 TPM4 FNBP1 PRKG1

9.47e-05183584818fd886e0188091310825f9145fa53328f2c979
ToppCellControl-T/NK_proliferative|Control / Disease group and Cell class

GPR19 CENPF DIAPH3 NOSTRIN

9.47e-0518358409c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

TPM2 TPM4 FNBP1 PRKG1

9.47e-05183584cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TPM2 TPM4 SEPTIN4 PRKG1

9.87e-0518558435d39a1d04c871edcfb749653538dc5fd0054281
ToppCellBAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters

TPM2 SEPTIN4 CENPF DIAPH3

9.87e-05185584e867ed55ab0df018f14bca824da09d36d83e12f9
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

TPM2 LAMA2 DGKB PRKG1

1.03e-04187584464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCelldroplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 DGKB PRKG1

1.03e-04187584accb8a78b885703a27d4b560f0053f03d82ff3af
ToppCellE17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TPM2 IL13RA1 DGKB PRKG1

1.03e-041875840dee138738b65531ff134a125b92234b5d0a653c
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9

IL13RA1 LAMA2 PRKG1 GALNT5

1.03e-04187584a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

TPM2 TPM4 FNBP1 PRKG1

1.05e-0418858434e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellFibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4)

TPM2 CENPF POLA1 DIAPH3

1.05e-04188584be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TPM4 CENPF POLA1 DIAPH3

1.05e-0418858415146fd2c5592ea84d20b1fdd172b39cd60b5bed
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEPTIN4 ING2 SPTY2D1 IL33

1.05e-041885845e13725136114e42d3b59647cf25e0f3c53abb54
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

TPM2 TPM4 FNBP1 LAMA2

1.07e-04189584b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

TPM2 TPM4 FNBP1 PRKG1

1.07e-041895846b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CCNH FNBP1 TSPYL2 TTC3

1.07e-04189584a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

1.09e-041905842e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NOL10 PRKG1 IL33

1.09e-041905841121eb607a984c59fbffe7220837fc178745aa55
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.09e-041905847e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NOL10 PRKG1 IL33

1.09e-04190584048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 LAMA2 PRKG1 IL33

1.09e-04190584562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

1.09e-041905840028f886c789ba238c031eae5d96acaed4af8c25
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

1.09e-0419058470c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCellP03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.09e-04190584979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 LAMA2 PRKG1 IL33

1.09e-04190584f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.09e-041905847fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CENPF POLA1 DIAPH3 NOSTRIN

1.09e-04190584d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAI1 STON1 SEPTIN4 NOSTRIN

1.12e-04191584df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCelldroplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM2 GPR19 SEPTIN4 DGKB

1.12e-04191584ff7874cc005760a8f3b2e8072fbe418b6bfacaa8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

1.12e-04191584107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPM2 TPM4 LAMA2 PRKG1

1.12e-04191584bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM2 SEPTIN4 LAMA2 NOSTRIN

1.14e-04192584fee99ca7e658963acf968aa724ef8c96cfc00a5d
ToppCellP03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SEPTIN4 LAMA2 PRKG1 NOSTRIN

1.14e-04192584063e119c4b58957643908f667e6cfd6f7517fd03
Drugconen

TPM2 TPM3 TPM4 SEPTIN4

5.07e-0815584CID000093117
Drugamphidinolide D

TPM2 TPM3 TPM4

1.56e-075583CID006439238
Drugeudistomin M

TPM2 TPM3 TPM4

1.56e-075583CID000145927
Drugdidansylcystine

TPM2 TPM3 TPM4

3.12e-076583CID000167721
DrugTopanol Ca

TPM2 TPM3 TPM4

5.45e-077583CID000092905
DrugTCNB

TPM2 TPM3 TPM4 SEPTIN4 POLA1 LAMA2

5.82e-07119586CID000008330
Drug5-IAF

TPM2 TPM3 TPM4 HSP90B1 PRKG1

7.14e-0766585CID000123822
DrugCP-31

TPM2 TPM3 TPM4

1.30e-069583CID000452624
DrugIASL

TPM2 TPM3 TPM4

1.86e-0610583CID002724305
DrugAC1NSKFN

TPM2 TPM3 TPM4 PRKG1

2.10e-0636584CID005311324
DrugAC1NRD2N

TPM2 TPM3 TPM4

3.40e-0612583CID005289322
DrugTMBr-3

TPM2 TPM3 TPM4

4.41e-0613583CID000518955
Drugbenzophenone-4-maleimide

TPM2 TPM3 TPM4 POLA1

5.22e-0645584CID000146390
DrugAC1MP21W

TPM2 TPM3 TPM4

5.60e-0614583CID003378340
Druggoniodomin A

TPM2 TPM3 TPM4

5.60e-0614583CID006440832
DrugA-G-T-C

TPM2 TPM3 TPM4

6.98e-0615583CID003037868
Drugdansyl chloride

TPM2 TPM3 TPM4 POLA1 TGM6

8.21e-06108585CID000011801
DrugDABMI

TPM2 TPM3 TPM4

1.04e-0517583CID000137371
Drugacrylodan

TPM2 TPM3 TPM4 HSP90B1

1.26e-0556584CID000104901
Drugbenzophenone-4-iodoacetamide

TPM2 TPM3 TPM4

1.48e-0519583CID000131289
DrugAC1NRBPQ

TPM2 TPM3 TPM4 ING2 POLA1

2.60e-05137585CID005288569
Drug7-azatryptophan

TPM2 TPM3 TPM4

2.68e-0523583CID005354789
Drugdansylaziridine

TPM2 TPM3 TPM4

2.68e-0523583CID000104008
DrugNSC 32050

TPM2 TPM3 TPM4

5.47e-0529583CID000022780
DrugN,N'-p-phenylenedimaleimide

TPM2 TPM3 TPM4

8.88e-0534583CID000076765
DrugDichloro-phen

TPM2 TPM3 TPM4

8.88e-0534583CID000003037
Druguranyl acetate

TPM2 TPM3 TPM4

1.06e-0436583CID000010915
DrugS H Y

TPM2 TPM3 SEPTIN4

1.24e-0438583CID004369485
DrugAC1Q5G4B

TPM2 TPM3 TPM4

1.24e-0438583CID000207983
Drugwortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A

TPM2 GPR19 STON1 LAMA2 IL33

1.39e-041955854467_UP
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

ABCA3 STON1 CENPF POLA1 U2SURP

1.53e-041995854523_DN
Drug3-(2-carboxyindol-3-yl)propionic acid

TPM2 TPM3 TPM4

1.80e-0443583CID000169313
Drugsilaned

TPM2 TPM3 TPM4

1.80e-0443583CID006335299
Drugethylene glycol tetraacetic acid

TPM2 TPM3 TPM4

1.93e-0444583CID000006207
DrugLS109

TPM2 TPM3 TPM4 JAK1 IL13RA1 IL33

2.16e-04338586CID000019920
Drugpemoline

TPM2 TPM3 TPM4

2.35e-0447583CID000004723
DiseaseNemaline Myopathy, Childhood Onset

TPM2 TPM3 NEB

2.51e-077583C0546125
DiseaseMyopathies, Nemaline

TPM2 TPM3 NEB

4.01e-078583C0206157
DiseaseNemaline myopathy

TPM2 TPM3 NEB

4.01e-078583cv:C0206157
DiseaseCongenital myopathy (disorder)

TPM2 TPM3 NEB

1.57e-0612583C0270960
DiseaseCap Myopathy

TPM2 TPM3

1.14e-053582C3710589
DiseaseInflammatory Myofibroblastic Tumor

TPM3 TPM4

5.67e-056582C0334121
DiseaseCongenital myopathy with fiber type disproportion

TPM2 TPM3

5.67e-056582cv:C0546264
DiseaseAutosomal Dominant Myotubular Myopathy

TPM2 TPM3

2.92e-0413582C3661489
DiseaseCentronuclear myopathy

TPM2 TPM3

2.92e-0413582C0175709
DiseaseX-linked centronuclear myopathy

TPM2 TPM3

2.92e-0413582C0410203
Diseasegamma-glutamylleucine measurement

NLN PRKG1

2.92e-0413582EFO_0021140
DiseaseCongenital Structural Myopathy

TPM2 TPM3

2.92e-0413582C0752282
DiseaseMyopathy, Centronuclear, 1

TPM2 TPM3

2.92e-0413582C4551952
DiseaseMyopathy, Centronuclear, Autosomal Dominant

TPM2 TPM3

3.40e-0414582C1834558
DiseaseTubular Aggregate Myopathy

TPM2 TPM3

3.40e-0414582C0410207
DiseaseAutosomal Recessive Centronuclear Myopathy

TPM2 TPM3

3.92e-0415582C3645536
Diseasejuvenile idiopathic arthritis

FNBP1 LAMA2 PRKG1

4.23e-0474583EFO_0002609
Diseasemacula measurement

CCNH STON1 ATAD2B SYNGAP1

5.28e-04189584EFO_0008375
DiseaseCongenital Fiber Type Disproportion

TPM2 TPM3

5.69e-0418582C0546264
Diseasechronotype measurement

CCNH AXDND1 STON1 ATAD2B GKAP1 STK31 SYNGAP1

1.66e-03882587EFO_0008328

Protein segments in the cluster

PeptideGeneStartEntry
TKKRKGYEDDDYVSK

CCNH

291

P51946
GYEDDDYVSKKSKHE

CCNH

296

P51946
KDSIYDSFDREAKEK

GPR19

386

Q15760
LEKAKEKYGVDDYSV

ABCA3

1666

Q99758
LSKLEYEEHKKEYED

GKAP1

136

Q5VSY0
YDAYVEELEKQEKTK

DNAI1

231

Q9UI46
EEKASELYKKFEKEF

DIAPH3

506

Q9NSV4
DYAYNLEKKSVLDKD

CFAP157

181

Q5JU67
TDMKYLLYEDEKDFK

CCDC83

346

Q8IWF9
KAIETDKEYYTVKDD

JAK1

1026

P23458
YTKSDFKEYEKEQDK

PPIL4

331

Q8WUA2
ENYKEDKYSEKSSGA

MAP10

471

Q9P2G4
VSNKAYEDAEAKAKY

PRKG1

331

Q13976
YEDAEAKAKYEAEAA

PRKG1

336

Q13976
NLKKDEEDTKFADYE

ATAD2B

1156

Q9ULI0
AERSYYLEKAKLEKE

HMGXB3

86

Q12766
DELMSEEAYEKYIKS

GCSH

156

P23434
KAYSNIKDYIDEAEK

LAMA2

1926

P24043
ESTVYDDYKFVTKKD

NOL10

366

Q9BSC4
KDVYEEFDEKIATKY

POLA1

411

P09884
KEIDDVYEKYKKEDD

ING2

61

Q9H160
KYDIYEKQTKEETDS

IL13RA1

401

P78552
PSKEVEEDEYKAFYK

HSP90B1

346

P14625
LKDEETRKDYDYMLD

DNAJC25

111

Q9H1X3
ESYEIYVEDLKKDEK

IL33

141

O95760
EDSDYDKLSDMVKYL

GRID2IP

851

A4D2P6
EEKTKEADEYLDKYC

CENPF

2851

P49454
KKNSKEEEEYKYTSC

FNBP1

56

Q96RU3
DFSTKDYLKDNLDKY

GALNT5

536

Q7Z7M9
TEDLYEVDKLKKECY

AXDND1

786

Q5T1B0
YAEYSTKKLKDVLEE

DGKB

21

Q9Y6T7
AYSKCKEYSDDKVQL

ING5

71

Q8WYH8
DDSDFDEKAKLKYYK

UTP3

366

Q9NQZ2
STEKLEKEDENYYQK

NOSTRIN

176

Q8IVI9
YKYSKVNKEEETDEN

IGF2R

2351

P11717
VDEVDYKTAEEKYIK

PWWP3A

671

Q2TAK8
EKSDDNSYDEKYLIA

SARS1

256

P49591
KLDPYDSSEDDKEYV

SEPTIN4

111

O43236
EQKEYENRDYKDFTK

SYNRG

976

Q9UMZ2
EYKKFLETYCVEEEK

UPF3A

176

Q9H1J1
EYKTDTDLYEFAKCK

PPWD1

266

Q96BP3
NDTYKYKTDGKEKEA

STXBP3

266

O00186
EIFGYDRKKYKDESD

SPTY2D1

621

Q68D10
KKEDEKAAAEIYEEF

U2SURP

106

O15042
EYDTKEVKYCTFSKD

CLHC1

146

Q8NHS4
DFIDSLEKTDDDKYK

NLN

226

Q9BYT8
DTEYTLYKKEEEIKT

STK31

986

Q9BXU1
EKEKDRYFSLSDKDA

ZBTB8A

126

Q96BR9
YEKVIEDFDKDQADY

TSPYL2

606

Q9H2G4
LEAASEKYSEKEDKY

TPM4

171

P67936
EKYSEKEDKYEEEIK

TPM4

176

P67936
RDESYYEKDSEKKGI

STON1

466

Q9Y6Q2
YEKDSEKKGIDILDY

STON1

471

Q9Y6Q2
EEYKLKEYSKSMDES

SYNGAP1

1176

Q96PV0
KEYTEYNEEKKKEAE

STAMBP

116

O95630
EYIKKGKEDYEESHQ

TTC3

1621

P53804
AEKEYDKAVQSYKDV

TTC21A

901

Q8NDW8
ADKYSTKEDKYEEEI

TPM2

211

P07951
TISYSKYKEDLTEDK

TGM6

566

O95932
QAEKYSQKEDKYEEE

TPM3

211

P06753
VVEDYKSKYEDEINK

KRT77

246

Q7Z794
SDKSYKAEYEEDKGK

NEB

701

P20929
QSDREYKKDYEKTKS

NEB

1121

P20929